NCT07437950
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07437950
Title Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Acronym MyeloMATCH
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Trinity Health IHA Medical Group Hematology Oncology - Brighton RECRUITING Brighton Michigan 48114 United States Details
Trinity Health IHA Medical Group Hematology Oncology - Canton RECRUITING Canton Michigan 48188 United States Details
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital RECRUITING Chelsea Michigan 48118 United States Details
Trinity Health Saint Mary Mercy Livonia Hospital RECRUITING Livonia Michigan 48154 United States Details
Trinity Health Saint Joseph Mercy Oakland Hospital RECRUITING Pontiac Michigan 48341 United States Details
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus RECRUITING Ypsilanti Michigan 48197 United States Details
San Juan City Hospital RECRUITING San Juan 00936 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field